FVB.129P2-Tiam1tm1Jgc/Cnbc

Status

Available to order

EMMA IDEM:05562
International strain nameFVB.129P2-Tiam1tm1Jgc/Cnbc
Alternative nameFVB-Tiam1 KO
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolTiam1tm1Jgc,
Gene/Transgene symbolTiam1

Information from provider

ProviderJohn Collard
Provider affiliationResearch - Animal Facility, The Netherlands Cancer Institute
Genetic informationMice that are deficient for the Rac activator Tiam1.
Phenotypic informationMice do not have an obvious phenotype and are fertile. However tumorigenicity is highly affected. In general tumor formation and growth is reduced but metastasis is enhanced.
References
  • Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours.;Malliri Angeliki, van der Kammen Rob A, Clark Kristopher, van der Valk Maarten, Michiels Frits, Collard John G, ;2002;Nature;417;867-71; 12075356
  • The rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development.;Malliri Angeliki, Rygiel Tomasz P, van der Kammen Rob A, Song Ji-Ying, Engers Rainer, Hurlstone Adam F L, Clevers Hans, Collard John G, ;2006;The Journal of biological chemistry;281;543-8; 16249175
  • Prognostic relevance of Tiam1 protein expression in prostate carcinomas.;Engers R, Mueller M, Walter A, Collard J G, Willers R, Gabbert H E, ;2006;British journal of cancer;95;1081-6; 17003780
  • Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.;Strumane K, Rygiel T, van der Valk M, Collard J G, ;2009;Journal of cancer research and clinical oncology;135;69-80; 18592271
  • Increased Rac activity is required for the progression of T-lymphomas induced by Pten-deficiency.;Strumane Kristin, Song Ji-Ying, Baas Inge, Collard John G, ;2008;Leukemia research;32;113-20; 17521720
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreCNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain
Animals used for archivingheterozygous FVB

Disease and phenotype information

MGI phenotypes (allele matching)
  • decreased incidence of tumors by chemical induction / MGI
  • decreased cell proliferation / MGI
  • abnormal apoptosis / MGI
  • increased malignant tumor incidence / MGI
  • increased squamous cell carcinoma incidence / MGI

Literature references

  • Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours.;Malliri Angeliki, van der Kammen Rob A, Clark Kristopher, van der Valk Maarten, Michiels Frits, Collard John G, ;2002;Nature;417;867-71; 12075356
  • The rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development.;Malliri Angeliki, Rygiel Tomasz P, van der Kammen Rob A, Song Ji-Ying, Engers Rainer, Hurlstone Adam F L, Clevers Hans, Collard John G, ;2006;The Journal of biological chemistry;281;543-8; 16249175
  • Prognostic relevance of Tiam1 protein expression in prostate carcinomas.;Engers R, Mueller M, Walter A, Collard J G, Willers R, Gabbert H E, ;2006;British journal of cancer;95;1081-6; 17003780
  • Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.;Strumane K, Rygiel T, van der Valk M, Collard J G, ;2009;Journal of cancer research and clinical oncology;135;69-80; 18592271
  • Increased Rac activity is required for the progression of T-lymphomas induced by Pten-deficiency.;Strumane Kristin, Song Ji-Ying, Baas Inge, Collard John G, ;2008;Leukemia research;32;113-20; 17521720

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).